Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P Edwards

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Cell Chemical Biology|September 5, 2020
Assessing IRAK4 Functions in ABC DLBCL by IRAK4 Kinase Inhibition and Protein DegradationJing Zhang, Liqiang Fu, Bin Shen, et al.
Journal of Medicinal Chemistry|July 19, 2021
Gut-Restricted Selective Cyclooxygenase-2 (COX-2) Inhibitors for Chemoprevention of Colorectal CancerZhuming Zhang, Avijit Ghosh, Peter J Connolly, et al.
Journal of Medicinal Chemistry|December 22, 2005
Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonistsJennifer D Venable, Hui Cai, Wenying Chai, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Discovery of a Potent and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase with Oral Anti-Inflammatory ActivityMark S Tichenor, John J M Wiener, Navin L Rao, et al.
Journal of Medicinal Chemistry|March 6, 2020
Discovery of a Gut-Restricted JAK Inhibitor for the Treatment of Inflammatory Bowel DiseaseKristi A Leonard, Lisa A Madge, Paul J Krawczuk, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2023
Development of small molecule inhibitors of natural killer group 2D receptor (NKG2D)Jocelyn Wang, Kohki M Nakafuku, Jeannie Ziff, et al.
Journal of Medicinal Chemistry|October 31, 2022
Discovery of JNJ-64264681: A Potent and Selective Covalent Inhibitor of Bruton's Tyrosine KinaseMark S Tichenor, John J M Wiener, Navin L Rao, et al.
ACS Medicinal Chemistry Letters|November 19, 2025
A Novel Small Molecule Allosteric Inhibitor of IL-17A from a DNA-Encoded LibraryMarcos E Milla, Jonathan M Blevitt, Steven D Goldberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2023
Identification of small-molecule protein-protein interaction inhibitors for NKG2DAaron A Thompson, Michael B Harbut, Pei-Pei Kung, et al.
Blood|June 21, 2024
Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemiasMin Chul Kwon, Jan Willem Thuring, Olivier Querolle, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Cell Chemical Biology|September 5, 2020
Assessing IRAK4 Functions in ABC DLBCL by IRAK4 Kinase Inhibition and Protein DegradationJing Zhang, Liqiang Fu, Bin Shen, et al.
Journal of Medicinal Chemistry|July 19, 2021
Gut-Restricted Selective Cyclooxygenase-2 (COX-2) Inhibitors for Chemoprevention of Colorectal CancerZhuming Zhang, Avijit Ghosh, Peter J Connolly, et al.
Journal of Medicinal Chemistry|December 22, 2005
Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonistsJennifer D Venable, Hui Cai, Wenying Chai, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Discovery of a Potent and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase with Oral Anti-Inflammatory ActivityMark S Tichenor, John J M Wiener, Navin L Rao, et al.
Journal of Medicinal Chemistry|March 6, 2020
Discovery of a Gut-Restricted JAK Inhibitor for the Treatment of Inflammatory Bowel DiseaseKristi A Leonard, Lisa A Madge, Paul J Krawczuk, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2023
Development of small molecule inhibitors of natural killer group 2D receptor (NKG2D)Jocelyn Wang, Kohki M Nakafuku, Jeannie Ziff, et al.
Journal of Medicinal Chemistry|October 31, 2022
Discovery of JNJ-64264681: A Potent and Selective Covalent Inhibitor of Bruton's Tyrosine KinaseMark S Tichenor, John J M Wiener, Navin L Rao, et al.
ACS Medicinal Chemistry Letters|November 19, 2025
A Novel Small Molecule Allosteric Inhibitor of IL-17A from a DNA-Encoded LibraryMarcos E Milla, Jonathan M Blevitt, Steven D Goldberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2023
Identification of small-molecule protein-protein interaction inhibitors for NKG2DAaron A Thompson, Michael B Harbut, Pei-Pei Kung, et al.
Blood|June 21, 2024
Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemiasMin Chul Kwon, Jan Willem Thuring, Olivier Querolle, et al.
Pageof 8